Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Passes Lab Cuts; Obama Budget Targets Include Imaging, DME

This article was originally published in The Gray Sheet

Executive Summary

Labs and test makers were caught off guard by a significant reimbursement cut passed in a payroll tax cut/physician payment fix bill. The same week, President Obama submitted a 2013 budget request that targets imaging and durable medical equipment with cuts and restrictions.

You may also be interested in...



IPAB’s Tough Road: Republicans Opt Not To Help Find Members

House Speaker Boehner and Senate Majority Leader McConnell “respectfully decline” the president’s request to submit names of individuals to serve on the Medicare Independent Payment Advisory Board.

Clinical Lab And DME Payments Face Cuts Under Obama Budget

The 2014 federal budget request submitted by President Obama April 10 includes proposals to cut clinical lab services and to limit Medicaid reimbursement for durable medical equipment, among other cuts that would affect the medtech industry.

IPAB Raised At Debate; Romney Advisor Skeptical Board Will Ever Meet, Even If Obama Wins

Strict conflict-of-interest restrictions will make it very challenging to get people confirmed to serve on the Independent Payment Advisory Board, established under health reform, according to a top advisor to Mitt Romney. IPAB was a contentious issue in last week’s presidential debate.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel